We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clarity Sought on EMA/HTA Parallel Approval Process
Clarity Sought on EMA/HTA Parallel Approval Process
Pharma is seeking greater clarity around a European Medicines Agency initiative to streamline regulatory approvals of drugs and national coverage decisions via parallel reviews by the EMA and health technology assessment bodies.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor